A recent ASO with a similar mechanism has been developed and tested in a mouse model of Dravet syndrome and was shown to increase productive SCN1A mRNA transcripts sixfold and the voltage-gated sodium channel α subunit Nav.1.1 by over 50% in a dose dependent manner [27]. This evidence concerns the gene SCN1A and Dravet syndrome.